ALPK3 and Schnyder corneal dystrophy: In a total of 775 (97.7%) patients included in the final evaluation with a mean follow-up time of 32.78 ± 27.58 months, 5 (18.5%) carriers of rare ALPK3 variants died, namely 1 SCD, 2 cardiac deaths, and 2 all-cause deaths.